| Literature DB >> 2115589 |
D A Walsh1, H W Moran, D A Shamblee, W J Welstead, J C Nolan, L F Sancilio, G Graff.
Abstract
A series of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid (amfenac) and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid were synthesized and evaluated for their cyclooxygenase inhibiting properties, antiinflammatory potency, and gastrointestinal irritation liability. One compound, 2-amino-3-(4-chlorobenzoyl)benzeneacetamide, possessed a therapeutic index 1 order of magnitude greater than that of indomethacin.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2115589 DOI: 10.1021/jm00170a039
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446